JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Textron
TXT
$15.4B
| $37.8M | 0.01% |
668,466
-8,144
| -1% | -$444K |
|
1127
Integer Holdings
ITGR
$4.26B
| $37.5M | 0.01% |
828,889
+295,620
| +55% | +$14.4M |
|
|
PSB
1128
DELISTED
PS Business Parks, Inc.
PSB
| $37.5M | 0.01% |
300,069
+26,319
| +10% | +$3.48M |
|
1129
Insight Enterprises
NSIT
$4.38B
| $37.3M | 0.01% |
974,256
-27,495
| -3% | -$1.12M |
|
|
VTA
1130
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
| $37.3M | 0.01% |
3,181,173
+72,166
| +2% | +$843K |
|
1131
PUT
Bristol-Myers Squibb
BMY
$132B
| $37.2M | 0.01% |
607,300
+204,900
| +51% | +$12.8M |
|
|
CA
1132
DELISTED
CA, Inc.
CA
| $37.1M | 0.01% |
1,115,527
+485,573
| +77% | +$16.1M |
|
1133
Skywest
SKYW
$4.34B
| $36.8M | 0.01% |
693,190
+48,642
| +8% | +$2.38M |
|
|
GRMN
1134
Garmin
GRMN
$60B
| $36.7M | 0.01% |
615,990
+439,960
| +250% | +$25.8M |
|
1135
Suburban Propane Partners
SPH
$1.18B
| $36.4M | 0.01% |
1,504,585
+444,534
| +42% | +$11.1M |
|
1136
Graco
GGG
$13.5B
| $36.4M | 0.01% |
804,925
-185,753
| -19% | -$8.04M |
|
1137
PUT
MetLife
MET
$62.1B
| $36.2M | 0.01% |
716,128
+603,928
| +538% | +$31.8M |
|
1138
Equifax
EFX
$21.4B
| $36.2M | 0.01% |
306,727
-252,264
| -45% | -$28.4M |
|
1139
PUT
Phillips 66
PSX
$81.4B
| $36M | 0.01% |
355,500
+167,400
| +89% | +$15.9M |
|
1140
Gerdau
GGB
$9.7B
| $35.9M | 0.01% |
12,172,860
+667,039
| +6% | +$1.82M |
|
1141
Bloomin' Brands
BLMN
$938M
| $35.9M | 0.01% |
1,682,100
-352,253
| -17% | -$6.75M |
|
1142
Insperity
NSP
$2.01B
| $35.8M | 0.01% |
625,031
-182,717
| -23% | -$9.67M |
|
1143
Jabil
JBL
$35.8B
| $35.7M | 0.01% |
1,361,358
+784,718
| +136% | +$22.2M |
|
1144
Waters Corp
WAT
$39.9B
| $35.7M | 0.01% |
184,981
+51,659
| +39% | +$9.98M |
|
|
DCUD
1145
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $35.7M | 0.01% |
691,563
+54,528
| +9% | +$2.83M |
|
1146
PENN Entertainment
PENN
$2.71B
| $35.7M | 0.01% |
1,140,283
-145,887
| -11% | -$3.94M |
|
|
IVC
1147
DELISTED
Invacare Corporation
IVC
| $35.7M | 0.01% |
2,118,202
+535,088
| +34% | +$8.71M |
|
|
ANDV
1148
CALL
DELISTED
Andeavor
ANDV
| $35.7M | 0.01% |
312,000
+82,000
| +36% | +$8.82M |
|
|
DHC
1149
Diversified Healthcare Trust
DHC
$2.14B
| $35.5M | 0.01% |
1,852,898
+250,661
| +16% | +$4.8M |
|
1150
BlackRock Corporate High Yield Fund
HYT
$1.37B
| $35.4M | 0.01% |
3,235,718
+79,907
| +3% | +$889K |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.